drugset / Trial / NCT02422017

Topical Timolol Benefit in Venous Ulcers

NCT02422017

Phase 2 Completed 42 enrolled Centre Hospitalier Universitaire, Amiens
RandomizedParallel-groupOpen-labelTreatment

Summary

Background: Venous Leg ulcers are a frequent pathology in dermatology and complex in their management. At the origin of high health costs and strong repercussions on quality of life for patients, they require long management and may be subject to possible complications. In spite of appropriate treatment, 50-60% of these ulcers are not healed at 24 weeks. Purpose: Topical beta adrenergic antagonists have shown efficacy in wound healing. The purpose of this study is to evaluate the efficacy and safety of treatment of chronic venous ulcers with topical timolol.

Timeline

Start
2015-04
Primary completion
2016-05
Completion
2018-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Timolol Other / unclassified 0.5 % Topical

Indications